Mylan Laboratories Limited Cisplatin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Cisplatin Export Records India — #5 Exporter, 18 Shipments, $775.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cisplatin

India Pharmaceutical Trade Intelligence

$12.8M233 Suppliers130 CountriesHS 30049047

ExportsIndia → TAIWAN12.4%India → HUNGARY10.7%

ImportsGERMANY → India$9.5K UNITED STATES → India$2.3K

#1 Supplier: FRESENIUS KABI

Mylan Laboratories Limited — Cisplatin Exporter #5 | $775.1K Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Cisplatin Exporter Profile

Indian Pharmaceutical Exporter · #5 for Cisplatin · $775.1K export value · DGFT Verified

Mylan Laboratories Limited is the #5 Indian exporter of Cisplatin with $775.1K in export value and 18 verified shipments. Mylan Laboratories Limited holds a 6.0% market share in Cisplatin exports across 1 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Cisplatin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Cisplatin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Cisplatin?

Country	Value	Shipments	Share
TAIWAN	$1.0M	20	13.2%
FRANCE	$922.2K	20	12.2%
UNITED STATES	$891.1K	27	11.8%
THAILAND	$876.5K	31	11.6%

Who Are the Top Buyers of Cisplatin from India?

Buyer	Country	Value	Orders
CSP MYLAN IRELAND LTD	FRANCE	$457.6K	10
FRESENIUS KABI TAIWAN LTD.	TAIWAN	$400.0K	8
SCIEGEN PHARMACEUTICALS INC	UNITED STATES	$329.4K	7
FRESENIUS KABI (THAILAND) LTD	THAILAND	$300.0K	6
FRESENIUS KABI TAIWAN LTD.,	TAIWAN	$250.0K	5
H B C L	VIETNAM	$231.8K	5
UKRPHARMGROUP LLC	HUNGARY	$200.0K	4
XXCORXXHEAXXHCAXX INXX	CANADA	$200.0K	4
FRESENIUS KABI TAIWAN LIMITED	TAIWAN	$200.0K	4
FRESENIUS KABI TAIWAN LTD	TAIWAN	$150.0K	3

India's Cisplatin is purchased by 584 buyers worldwide. The top buyer is CSP MYLAN IRELAND LTD (FRANCE), followed by FRESENIUS KABI TAIWAN LTD. and SCIEGEN PHARMACEUTICALS INC.

How Does Mylan Laboratories Limited Compare to Nearest Cisplatin Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	VENUS REMEDIES LIMITED	$1.7M	121	22	$13.7K
3	INTAS PHARMACEUTICALS LIMITED	$1.5M	73	13	$19.9K
5	MYLAN LABORATORIES LIMITED ★	$775.1K	18	1	$43.1K
6	GLAND PHARMA LIMITED	$530.1K	11	1	$48.2K
7	NAPROD LIFE SCIENCES PRIVATE LIMITED	$507.6K	29	8	$17.5K

Mylan Laboratories Limited ranks #5 among 233 Indian Cisplatin exporters. Average shipment value of $43.1K compared to the market average of $41.2K. The closest competitors by value are VENUS REMEDIES LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Cisplatin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	300	17.6%
SAHAR AIR	281	16.5%
DELHI AIR CARGO ACC (INDEL4)	260	15.3%
DELHI AIR	237	13.9%
Bombay Air	104	6.1%
Delhi Air	53	3.1%
Delhi Air Cargo	37	2.2%
HYDERABAD ACC (INHYD4)	35	2.1%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Cisplatin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cisplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 130+ countries, 584+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cisplatin

Cisplatin

Mylan Laboratories Limited — Cisplatin Exporter Profile

Mylan Laboratories Limited — Cisplatin Export Profile: Buyers & Destinations

Where Does India Export Cisplatin?

Who Are the Top Buyers of Cisplatin from India?

What Is India's Total Cisplatin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Cisplatin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Cisplatin Exporters?

Regulatory Requirements: Exporting Cisplatin to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Cisplatin Exporters?

Which Indian Ports Ship Cisplatin Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Cisplatin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cisplatin Export Data from Mylan Laboratories Limited

Cisplatin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source